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Summary  
 
Since its first description in the early part of the twentieth century, struma ovarii has elicited 
considerable interest because of its many unique features; however, at present a number of 
aspects remain enigmatic. Although the typical presentation is that of a pelvic mass, unusual 
clinical manifestations such as hyperthyroidism, ascites, and Meigs' syndrome have been 
recognised. Uncommon macroscopic and especially histological patterns in struma can cause 
difficulties in diagnosis. Cystic strumas are challenging to diagnose both macroscopically and 
histologically. Proliferative changes within struma can be misdiagnosed as cancer. In regard 
to the occurrence of thyroid-type carcinoma in struma ovarii, precise terminology should be 
utilised, and the term 'malignant struma ovarii' should be avoided because it has been used for 
several different pathological entities. Papillary carcinoma is the most commonly occurring 
thyroid-type carcinoma in ovarian struma; however, cases of follicular carcinoma are not 
infrequent. Histological malignancy in struma does not necessarily equate with biological 
malignancy, and the majority of thyroid-type carcinomas do not spread beyond the ovary. 
Strumal carcinoid, a neoplasm apparently unique to the ovary containing elements of both 
struma and carcinoid, has been misdiagnosed as 'malignant struma ovarii' in the past. The 
differential diagnosis of extra-ovarian spread of struma includes the usual types of thyroid 
cancer, minimal deviation follicular carcinoma, and peritoneal strumosis. This review 
emphasises articles both recent and past that have significantly advanced our knowledge of 
struma ovarii and related neoplasms.  
 
 
 INTRODUCTION  
 
Unusual aspects of struma ovarii have elicited considerable interest since its first 
description.  Although it had been described earlier, Ludwig Pick first recognised that 
struma ovarii was composed of thyroid tissue in the early part of the twentieth century and 
suggested that ovarian goitres are actually teratomas in which thyroidal elements have 
overgrown the other tissues.1,2  In 1933, Plaut showed that the thyroid tissue in struma 
ovarii is morphologically, biochemically, and pharmacologically identical to that of the 
cervical thyroid gland.3 Smith reviewed the literature, and found 152 cases up to 1946 of 
which approximately 5% had extra-ovarian di~semination.4  In their monograph on ovarian 
tumours, Fox and Langley concisely and accurately summarised our knowledge of struma 
ovarii up to 1976.5 In the same year Yannopoulos and associates comprehensively reviewed 
the literature regarding malignant struma ovari.6 In the latest World Health Organization 
(WHO) classification, struma ovarii and malignant thyroid tumours arising within struma 
are included in the thyroid tumour group under the heading monodermal teratoma and 
somatic-type tumours associated with dermoid cysts.7 In that regard struma ovarii is the 
most common type of monodermal teratoma, accounting for nearly 3% of all ovarian 
teratomas.8 It is defined as an ovarian teratoma that is composed predominantly (over 50%) 
or entirely of thyroid tissue or forms a macroscopically recognisable component of mature 
cystic teratoma.9 Also included in this category, however, are cases of mature cystic 
teratoma having less than 50% thyroid tissue that contain functional or histologically or 
biologically malignant thyroid tissue.10    
 
Although thyroid tissue can be identified histologically in up to 20% of cases of mature 
cystic teratoma, it is macroscopically recognised in less than 3%.9 The age incidence of 
struma ovarii is similar to that of mature cystic teratoma. The peak age incidence of 
struma is in the fifth decade, but cases have been reported in older post-menopausal 
women and uncommonly occur in pre-pubertal girls.9 In addition to the usual signs and 
symptoms of a pelvic mass, ascites occurs in one-third of cases, and occasional patients 
have Meigs' syndrome. Clinical evidence of hyperthyroidism occurs in about 5% of 
cases.9 Thyrotoxic crisis is a rare, but life threatening complication following excision of 
struma in which hyperthyroidism was not diagnosed pre-operatively.11 Struma ovarii is 
the most common type of ovarian tumour associated with peripheral steroid cell 
formation.12 Strumal carcinoid, a neoplasm unique to the ovary, is composed of both 
monodermal teratoma (struma) and secondary somatic tumour (carcinoid). Although 
classified by the WHO as a form of carcinoid, it alternatively can be interpreted as 
struma with a secondary somatic neoplasm and for that reason will be discussed in this 
review. Struma ovarii containing thyroid- type carcinoma must be distinguished from 
rare cases of papillary or follicular thyroid carcinoma metastatic to the ovary.13,14 
Extrathyroidal strumas are not limited to the ovary. We are aware of two cases of struma 
salpingii, one of which was associated with struma ovarii.15,16  A case of struma uteri 
attached to the uterine cervix and vaginal wall unaccompanied by other teratomatous 
elements has recently been reported.17 Infrequently struma has been described in the 
testis.18,19
 
UNUSUAL MACROSCOPIC APPEARANCES  
 
Struma is typically identified as a brown or green-brown solid, gelatinous mass, either in 
pure form or less frequently associated with mature cystic teratoma or rarely with mucinous 
cystadenoma or Brenner tumour (Fig. lA). Although most cases of struma ovarii are solid or 
solid and cystic on macroscopic examination, predominantly or entirely cystic tumours can 
lead to errors in diagnosis (Fig. lB).20 Most of the latter cases are multilocular cysts, but 
about 10% are unilocular. In most cases small solid areas protrude into the cyst lumens or 
are noted in the cyst wall. The non-specific histological appearance of large areas of many 
cystic strumas compounds the diagnostic difficulty (see following section).  
 
UNUSUAL HISTOLOGICAL PATTERNS AND CELL TYPES 
  
Struma ovarii typically consists of normal-appearing thyroidal tissue composed of thyroid 
follicles of various sizes and often is associated with mature cystic teratoma (Fig.2A,B). 
Occasionally, the thyroid tissue may show changes associated with hyperactivity, 
hypoactivity, or have the appearance of an adenomatous nodule or nodular goiter.8 
Histologically, ovarian struma can also resemble thyroid adenoma of follicular, fetal, or 
embryonal type or thyroid carcinoma;9,21  however, if there are unequivocal histological 
features of malignancy, this finding should be indicated in the diagnosis.  Although in 
some cases the appearance has been recognized as that of thyroid adenoma, these tumors 
have generally been reported under the term ‘struma ovarii.’  Perhaps our understanding 
of these lesions and assessment of their malignant potential would be better served by 
diagnosing such lesions as ‘struma ovarii with features of multinodular adenomatous 
goitre or thyroid-type adenoma,’ specifying the type.  Changes of toxic goitre occasionally 
may be seen in struma ovarii associated with clinical hyperactivity, including small 
follicles lined by hyperplastic epithelium with pseudopapillary infoldings as well as pale 
and peripherally vaculolated colloid.  Focal lymphocytic infiltrates can occur.  These 
histological alterations must be distinguished from thyroid-type papillary carcinoma.  
Rarely, struma takes the form of Hashimoto’s (automimmune) thyroiditis.22,23 
 
 
Although typical struma ovarii is readily identified, unusual histolgical manifestation may 
lead to failure of recognition.24  These include solid patterns, prominent microfollicles 
conveying  a pseudotubular appearance, abundant eosinophilic cytoplasm imparting an 
oxyphilic appearance, and abundant clear cytoplasm.  Not infrequently, the various patterns 
and cell types overlap.  Recognition of these patterns together with a careful search for 
thyroid follicles, the presence in some cases of birefringent calcium oxalate crystals in the 
colloid, and immunohistochemical stains for thyroglobulin or thyroid transcription factor-1 
(TTF-1) will confirm the diagnosis in problematic cases. 
 
As stated earlier, struma ovarii can have a histological appearance that mimics thyroid-type 
adenoma.  Of the unusual histological growth patterns, the solid pattern in most often 
encountered.  This type consists of nests or sheets of tumor cells that may be interrupted to 
a variable extent by small numbers of thyroid follicles, usually microfollicles.  In some 
cases trabecular, pseudotubular, or thin, cord-like formations can occur (Fig. 2C).  The 
microfollicular pattern is the next most common type encountered.  On low magnification, 
microfollicles are pominent which are either empty or contain eosinophilic colloid.   
 
In neoplasms displaying either a solid or microfollicular pattern the tumour cells usually 
have moderate amounts of pale eosinophilic cytoplasm, but in some instances most of the 
neoplastic cells have abundant eosinophilic or clear cytoplasm.  Tumours with an oxyphilic 
appearance may be confused with a variety of oxyphilic cell tumours both primary and 
metastatic including hepatoid carcinoma, oxyphilic Sertoli cell tumour, and metastatic 
melanoma and hepatocellular carcinoma; cases of struma with a clear cell appearance must 
be distinguished from primary ovarian clear cell adeonocarcinoma or metastatic renal cell 
carcinoma.9,24  
 
Struma ovarii can mimic ovarian tumours in the sex-cord-stromal category.  Struma having  
a pseudotubular pattern can mimic Sertoli cell tumour, and one with a cord-like 
arrangement with small follicles resembles granulose cell tumour.  Strumas with a nest-like 
pattern separated by delicate fibrovascular septa resemble paraganglioma.  Recognition of 
areas of the neoplasm that exhibit the more typical patterns of struma ovarii and/or 
immunohistochemical stains for thyroglobulin or TTF-1 can assist in the differential 
diagnosis. 
 
The various patterns of struma can be confused with carcinoid.  The microfollicular variant 
can be confused with acinar formation in an insular carcinoid, and a trabecular pattern can 
be mistaken for trabecular or strumal carcinoid. 
 
As mentioned in the previous section, the epithelium lining the variably sized cysts of 
predominantly cystic strumas can have a largely non-specific appearance composed of 
flattened to cuboidal cells.20  Clues to the correct diagnosis include the identification of 
thyroid follicles in the cyst wall or in fibrous septa separating locules of tumour, the 
detection of foci of typical struma through ample sampling, or the association with mature 
cystic teratoma.  In some cases, immunohistochemical staining for thyroglobulin or TTF-1 
may be required to establish or confirm the diagnosis.25 
  
Occasional strumas contain mucin in follicular lumens or are admixed with mucinous 
elements.  In patients who have been subjected to pelvic radiation, isolated nuclear atypia 
can occur, and these alterations need to be distinguished from those of malignancy.21 
 
ASSOCIATION OF STRUMA OVARII WITH NON-THYROID NEOPLASMS 
 
Struma ovarii is an obligatory component of strumal carcinoid and occasionally is 
associated with other neoplasms of somatic type including Brenner tumor and mucinous 
cystadenoma that also can accompany mature cystic teratoma.   
 
Strumal carcinoid 
 
Strumal carcinoid is a distinctive form of ovarian teratoma characterized by a mixture of 
thyroid tissue and carcinoid; other teratomatous elements are noted in over 80% of cases.  It 
is the second most common type of primary ovarian carcinoid and is usually discussed 
along with other forms of that neoplasm.  We interpret strumal carcinoid as a monodermal 
teratoma (struma) with a secondary somatic tumour (carcinoid) (Table 1).  Strumal 
carcinoid has been reported in a patient with multiple endocrine neoplasia syndrome type 
2A (Sipple’s syndrome).27  Metastasis in strumal carcinoid is uncommon, occurring in 
about 2% of cases.26,28 
 
The thyroid and carcinoid components can be intimately admixed or may be distinct 
macroscopically and histologically (Fig. 3). Even in the cases where the thyroid and 
carcinoid components are distinct, there is usually an admixture of these elements at their 
interface, suggesting that the carcinoid arises from the struma. In areas where the thyroid 
tissue is pure, it can resemble normal thyroid, colloid goitre, macrofollicular or 
microfollicular adenoma, or rarely can be manifest as papillary or follicular thyroid-type 
carcinorna.26 The neoplastic neuroendocrine cells have a higher growth rate and 
progressively invade the struma, replacing the follicular lining cells.29 Glands or cysts 
containing goblet cells can occur, and occasionally the tumour is associated with a 
mucinous (goblet cell) carcinoid.30  The carcinoid component has a trabecular pattern in 
about one-half of cases, most of the others show a mixed trabecular and insular pattern, and 
occasional cases have a pure insular appearance.9 
 
The thyroidal component of strumal carcinoid expresses TTF-1; however, the carcinoid 
element is for the most part negative, indicating that the carcinoid component bears no 
relationship to thyroidal differentiation.31 The neuroendocrine component of strumal 
carcinoid is frequently positive for chromogranin, somatostatin, and serotonin.32 The 
thyroidal component is positive for thyroxine, and several neoplasms have contained 
calcitonin-positive cells (Fig. 4);29,33 however, calcitonin has also been detected in 2 of 15 
cases of trabecular carcinoid, a neoplasm that . does not contain thyroid elements.34 In 
strumal carcinoid amyloid deposits can occur in proximity to the calcitonin-producing 
cells.35,36 Despite these similarities, the histological appearance of strumal carcinoid differs 
significantly from that of medullary thyroid carcinoma. Neurosecretory granules observed 
by electron microscopy resemble those of both trabecular carcinoid and medullary thyroid 
carcinoma (Fig. 5). On occasion, strumal carcinoid, like trabecular carcinoid, can cause 
severe constipation due to tumour-producing peptide YY.37,38 Constipation resolves after 
removal of the tumour. The neoplastic neuroendocrine cells are strongly positive for peptide 
YY by immunocytochernistry.  
 
The differential diagnosis of strumal carcinoid includes trabecular carcinoid, a 
neoplasm that is only one-third as common as strumal carcinoid. Cases with a 
presumptive diagnosis of trabecular carcinoid should be thoroughly sampled 
histologically for evidence of thyroid follicles. In the older literature cases of strumal 
carcinoid were misdiagnosed as 'malignant struma ovarii'; however, the histological 
appearance of strumal carcinoid does not closely resemble that of the various types of 
thyroid carcinoma.  
 
Brenner tumour  
 
Although the vast majority of ovarian Brenner tumours are of surface epithelial origin, in at 
least nine cases they have been associated with struma ovarii suggesting a germ cell  
origin.39-41  Mature cystic teratoma was identified in the ipsilateral or contralateral ovary in 
most cases. 
 
Mucinous cystadenoma  
 
A case of struma ovarii with coexistent mucinous cystadenoma in the absence of biphasic or 
triphasic teratoma has been reported42 and represents mixed endodermal differentiation in 
monodermal teratoma. This association is not unexpected, since endodermally-derived 
mucinous cystadenoma also occurs in cases of mature cystic teratoma.  
 
ASSOCIATION OF STRUMA OVARll WITH THYROID-TYPE CARCINOMA  
 
With regard to the occurrence of malignancy in struma ovarii the literature is confusing 
since many of the cases reported as 'malignant struma ovarii' have been misdiagnosed and 
no large series has been carefully documented. A number of cases reported as 'malignant 
struma ovarii' in the older literature were actually examples of strumal or insular 
carcinoid.10 Due to inadequate sampling of the primary tumour an important component 
may be missed leading to an inaccurate diagnosis. Uniformly accepted criteria for 
malignancy in struma ovarii have yet to be established.9  Because of varying usage and the 
lack of a precise definition, it is recommended that the term 'malignant struma ovarii' no 
longer be utilised for cases of malignancy that develop in ovarian struma. The term, 
'thyroid-type carcinoma originating in struma ovarii' (specifying the type) is more 
appropriate to describe this entity.  
 
Strict histological criteria are required for the diagnosis of carcinoma because 
proliferative changes including areas of densely packed follicles or pseudopapillary 
formations in the struma can be confused with malignancv.21 Several different types of 
thyroid carcinoma arising in struma ovarii have been described. Among these are papillary 
carcinoma43 including the follicular variant,44,45 follicular carcinoma46 including its 
oncocytic variant,47 and arguably insular carcinoma,48 a type of poorly differentiated 
carcinoma. To our knowledge the oxyphilic variant of papillary carcinoma, anaplastic 
carcinoma, medullary carcinoma, or other uncommon forms of thyroid carcinoma have not 
been reported in association with struma ovarii.  
 
Papillary carcinoma is the most common thyroid-type carcinoma to occur in struma 
ovarii. Criteria for papillary carcinoma include overlapping, ground glass, irregularly 
contoured nuclei lining papillary formations with fibrovascular cores or vascular invasion; 
however, not all these features need be identified to establish the diagnosis (Fig. 6).21 These 
tumours exhibit nuclear features similar to those of their counterparts in the thyroid gland 
including grooves, intranuclear cytoplasmic inclusions, and finely granular chromatin. The 
identification of psammoma bodies in the context of a thyroid-type papillary neoplasm is 
highly supportive of the diagnosis of malignancy. Similar nuclear features are present in the 
follicular variant of papillary thyroid carcinoma; however, papillary architecture is absent.  
 
Follicular carcinoma is the second most common type of carcinoma to arise in struma 
ovarii and varies in its degree of differentiation (Fig. 7). The diagnosis of well-differentiated 
follicular thyroid-type carcinoma is more difficult than that of papillary carcinoma since 
capsular invasion is an important criterion in follicular carcinoma located in the neck but 
there is usually no capsule in the corresponding ovarian lesion. In such cases the 
identification of invasion into the surrounding ovarian tissue, vascular invasion, or 
metastases is evidence of malignancy. The oncocytic variant of follicular carcinoma is 
similar in appearance to that of classical follicular carcinoma, but the cytoplasm is 
abundant, eosinophilic, and granular.  
 
Insular carcinoma is infrequent. It is a morphologically distinct type of poorly 
differentiated thyroid carcinoma of follicular cell origin that forms nests or islands 
composed of monotonous small cells with rounded nuclei and scant cytoplasm.49 Although 
the tumour predominantly has a solid infiltrative growth pattern, microfollicles are 
frequently encountered, some of which contain colloid. Vascular invasion is common, and 
variable numbers of mitoses are present.  
These histological changes of malignancy in struma, however, often do not equate with 
clinical malignant behaviour, and most cases of thyroid-type carcinoma arising in struma 
ovarii do not have a clinically aggressive course. Occasional cases of thyroid-type 
carcinoma may arise in the absence of detectable benign struma ovarii. In these cases the 
malignancy may arise from thyroid tissue in mature cystic teratoma and overgrow the tissue 
without forming typical struma ovarii. 
 
Struma ovarii containing thyroid-type carcinoma must be distinguished from rare 
instances of follicular, papillary, or other types of thyroid carcinoma metastatic to the 
ovary.13,14 Cases of the latter are not associated with mature cystic teratoma and often 
show the typical patterns of metastatic tumour in the ovary. They usually have a prior 
history of thyroid carcinoma, but in one case the primary tumour had been resected 12 
years earlier.14
 
EXTRA-OVARIAN SPREAD OF STRUMA HAVING AN INNOCUOUS 
APPEARANCE  
 
If thyroid-type carcinomas of conventional type spread to the peritoneum, the diagnosis 
is easily made. However, the occurrence in the peritoneal cavity of thyroid tissue that 
has an innocuous appearance causes diagnostic and nosological problems.  
 
Stnuna ovarii with peritoneal dissemination (peritoneal stnunosis)  
 
Uncommonly, cases of struma ovarii with extra-ovarian spread can have a histologically 
benign appearance. The term 'peritoneal strumosis' or 'strumatosis' has been applied by 
some for benign-appearing peritoneal implants detected at the time of laparotomy in the 
absence of an identifiable somatic thyroid-type carcinoma (Fig. 8).50 The terminology has 
not been uniformly applied, and two similar cases were referred to as 'malignant struma 
ovarii' with peritoneal dissemination.51  
 
These cases typically have an indolent clinical course, however only a few cases have 
long follow up.50,51 One explanation of these cases is that they represent implants -from 
struma ovarii or mature cystic teratoma containing thyroid tissue due to capsular tears or 
tumour rupture, although to our knowledge such findings have never been demonstrated. 
Alternatively, it has been suggested that they represent spread from an extremely well-
differentiated follicular carcinoma. We believe the designation 'struma ovarii with 
peritoneal dissemination' is most appropriate to indicate our current state of knowledge 
regarding this concept. 
 
Minimal deviation follicular thyroid-type carcinoma  
 
Peritoneal strumosis must be distinguished from well-differentiated follicular carcinoma 
arising in struma ovarii that spreads to the peritoneum. A diagnosis of peritoneal strumosis 
is not tenable when follicular carcinoma is present or suspected in the ovary. When 
follicular thyroid-type carcinoma arising in struma spreads beyond the ovary, it may involve 
the peritoneum as well as para-aortic lymph nodes and, when more advanced, the liver and 
lungs. We have encountered a case we interpret as extremely well-differentiated follicular 
carcinoma which had an innocuous appearance resembling that of colloid goitre, yet spread 
to the peritoneum and para-aortic lymph nodes (Fig. 9). Such cases are similar to those 
described in the thyroid gland that show such a high degree of differentiation that they 
simulate the appearance of non-neoplastic thyroid.49 In fact similar cases occurring in the  
thyroid were referred to in the past by the incorrect and deservedly obsolete expression 
'benign metastasising goitre'. We believe the term 'minimal deviation follicular thyroid-type 
carcinoma' is appropriate when the lesion arises in struma ovarii. Because of its innocuous 
appearance, extra-ovarian dissemination must occur before the diagnosis is established. The 
corollary of this hypothesis is that cases with the appearance of typical struma ovarii can 
rarely metastasise in the absence of atypical features.  
 
As indicated above, it is not possible to distinguish peritoneal strumosis from this variant 
of follicular carcinoma histologically. As far as we know, in all cases that can be interpreted 
as peritoneal strumosis in the literature, the extra-ovarian spread was detected at the time of 
initial diagnosis of the struma.50-53 It is likely that cases where extra-ovarian spread occurs 
subsequent to the excision of the struma are, in fact, metastatic thyroid carcinoma. If pelvic 
lymph nodes or distant metastases occur, then the diagnosis of metastatic carcinoma can be 
fully established. Nevertheless, there are cases where the diagnosis is problematic, and it 
may be necessary to rely on outcome data to establish the diagnosis. To establish a 
diagnosis of strumosis, a follow up of at least 5 years without evidence of progression is 
required. However, in cases with an equivocal diagnosis treated by thyroidectomy followed 
by radioactive iodine therapy, it may never be possible to reach a definite conclusion.  
 
CONCLUSIONS  
 
Although it has been more than 100 years since the first description of struma ovarii, a 
number of aspects remain enigmatic. Better recognition of the wide range of macroscopic 
and histological features of struma will improve accuracy of diagnosis. More precise 
description of the spectrum of histological changes using terminology applicable to the 
thyroid gland as well as accurate diagnosis and long term follow up will improve our 
knowledge of this entity. Precise criteria should be used for the histological diagnosis of 
malignancy in cases of struma confined to the ovary with consideration of the proliferative 
changes that can mimic cancer. Malignant cases should be diagnosed according to the 
histological criteria for the various forms of thyroid-type carcinoma. Our assessment of the 
prognosis of patients with extra-ovarian dissemination of struma must include a critical 
appraisal of cases diagnosed as 'malignant struma ovarii' in the literature. The relationship 
of minimal deviation follicular carcinoma to peritoneal strumosis must be studied in order 
to determine if there is a reproducible way to diagnose peritoneal strumosis prospectively 
and indeed to establish whether it exists as a distinct entity.  
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FIGURES 
 
 
Figure 1 
 
Struma ovarii  
(figures courtesy of Drs. Robert E. Scully and Robert H. Young, Boston, MA USA).   
 
(A) Note the solid, red-brown area of thyroid tissue, on the left adjacent to mature cystic 
teratoma.   
 
(B) Cystic struma consists of a multiloculated cyst that contains green to brown gelatinous 
material. 
 
 
 
 
 
 
  
 
 
 
Figure 2 
 
Struma ovarii.   
 
(A)  Colloid-containing follicles of varying size are noted.  Some of the follicles are 
irregular in shape.   
 
(B)  Macrofollicular and microfollicular pattern is contiguous to ciliated columnar 
epithelium of mature cystic teratoma on the left.   
 
(C) Struma ovarii with features of thyroid adenoma.  A solid nested pattern is observed 
adjacent to a trabecular pattern.  Ovarian stroma is noted in the upper portion of the field.  
Inset:  Note the trabecular pattern. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
 
Strumal carcinoid. 
 
(A) Large brown nodule of struma is sharply demarcated from the white to pale yellow 
carcinoid.  Note that a nodule of carcinoid is pushing into the struma suggesting that the 
former has a higher growth rate (figure courtesy of Dr. Fattaneh A. Tavassoli, New 
Haven, CT, USA).   
 
(B) Thyroid tissue composed of numerous colloid-containing follicles is noted on the right, 
and trabecular carcinoid is seen on the left. 
 
 
 
 
 
 
 
 Figure 4 
 
Strumal carcinoid. 
 
(A) Immunostain for thyroxine is mostly positive in the follicles. 
   
(B) Immunostain for calcitonin is positive in both the interfollicular areas and in the 
follicular lining epithelium.  The latter finding is due to neuroendocrine cells 
progressively replacing the follicular epithelium due to a higher growth rate. 
 
 
 
 
 
 
 
 
 
 
Figure 5 
 
Strumal carcinoid. 
 
Electron micrograph shows thyroid follicular cells adjacent to colloid at the top of the field 
and scattered neuroendocrine cells containing abundant small, uniform round 
neurosecretory granules among other follicular cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 
 
Papillary thyroid-type carcinoma arising in struma ovarii associated with mature cystic 
teratoma. 
 
(A)  The papillary neoplasm on the right is adjacent to sebaceous elements.   
 
(B)  Higher magnification shows fibrovascular cores.  
 
Inset:  Note the nuclear features of papillary carcinoma including crowded, overlapping 
nuclei with occasional optical clearing and prominent amphophilic nucleoli. 
 
 
 
 
 
 
Figure 7 
 
Invasive follicular carcinoma arising in struma ovarii.   
 
Note several follicles of struma to the left, separated from a focus of invasive, poorly-
differentiated follicular carcinoma by fibrous stroma (figure courtesy of Drs. Zhang Jianmin 
and Longdi Fan, Weiling, China).   
 
 
 
Figure 8 
 
Struma ovarii with peritoneal dissemination (peritoneal strumosis).   
 
Omental nodule composed of innocuous-appearing thyroid tissue has a thick fibrous 
capsule containing fat (figure courtesy of Dr. O. Ljungberg, Malmö, Sweden).   
 
 
 
Figure 9 
 
Metastatic minimal deviation follicular carcinoma arising in struma ovarii.   
 
(A)  Omental nodule composed of innocuous-appearing thyroid follicles surrounded by fat.  
The findings are histologically indistinguishable from those of peritoneal strumosis.   
 
(B) Para-aortic lymph node shows similar thyroid follicles surrounded by lymphoid follicles 
containing germinal centers.  Nuclear alterations of papillary thyroid-type carcinoma are 
absent. 
 
 
 
 
 
 
 
  
 
 
 
Table 1 
 
Classification of thyroid tumor group 
_______________________________________________________ 
 
1. Struma ovarii 
a. Typical  
b. Variant with non-thyroid type neoplasm 
i. Variant with carcinoid (strumal carcinoid) 
ii. Variant with Brenner tumor 
iii. Variant with mucinous cystadenoma 
c. Variant with thyroid-type tumor 
i. Papillary carcinoma 
1. Typical 
2. Follicular variant 
ii. Follicular carcinoma 
1. Typical 
2. Minimal deviation variant 
3. Oncocytic variant 
iii. Insular carcinoma 
_________________________________________________________ 
The oncocytic variant of papillary carcinoma, anaplastic carcinoma, medullary  
carcinoma, and other rare forms have not thus far been reported. 
 
